Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph P Balthasar

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Journal of Pharmaceutical Sciences|November 25, 2018
Development and Evaluation of a Physiologically Based Pharmacokinetic Model for Predicting the Effects of Anti-FcRn Therapy on the Disposition of Endogenous IgG in HumansTommy Li, Joseph P Balthasar
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|January 25, 2005
High-performance liquid chromatographic assay for the determination of total and free topotecan in the presence and absence of anti-topotecan antibodies in mouse plasmaJin Chen, Joseph P Balthasar
Biomolecules|October 18, 2018
FcRn Expression in Wildtype Mice, Transgenic Mice, and in Human TissuesTommy Li, Joseph P Balthasar
The AAPS Journal|July 29, 2009
Investigation of the influence of FcRn on the distribution of IgG to the brainAmit Garg, Joseph P Balthasar
Molecular Pharmaceutics|July 31, 2012
Investigation of the role of FcγR and FcRn in mAb distribution to the brainLubna Abuqayyas, Joseph P Balthasar
International Journal of Pharmaceutics|September 29, 2012
Application of knockout mouse models to investigate the influence of FcγR on the tissue distribution and elimination of 8C2, a murine IgG1 monoclonal antibodyLubna Abuqayyas, Joseph P Balthasar
Journal of Pharmacokinetics and Pharmacodynamics|July 20, 2007
Physiologically-based pharmacokinetic (PBPK) model to predict IgG tissue kinetics in wild-type and FcRn-knockout miceAmit Garg, Joseph P Balthasar
Blood|November 30, 2006
Comparison of the effects of antibody-coated liposomes, IVIG, and anti-RBC immunotherapy in a murine model of passive chronic immune thrombocytopeniaRong Deng, Joseph P Balthasar
The AAPS Journal|April 25, 2012
Pharmacokinetic mAb-mAb interaction: anti-VEGF mAb decreases the distribution of anti-CEA mAb into colorectal tumor xenograftsLubna Abuqayyas, Joseph P Balthasar
Journal of Pharmaceutical Sciences|November 14, 2018
Application of Physiologically Based Pharmacokinetic Modeling to Predict the Effects of FcRn Inhibitors in Mice, Rats, and MonkeysTommy Li, Joseph P Balthasar
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Journal of Pharmaceutical Sciences|November 25, 2018
Development and Evaluation of a Physiologically Based Pharmacokinetic Model for Predicting the Effects of Anti-FcRn Therapy on the Disposition of Endogenous IgG in HumansTommy Li, Joseph P Balthasar
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|January 25, 2005
High-performance liquid chromatographic assay for the determination of total and free topotecan in the presence and absence of anti-topotecan antibodies in mouse plasmaJin Chen, Joseph P Balthasar
Biomolecules|October 18, 2018
FcRn Expression in Wildtype Mice, Transgenic Mice, and in Human TissuesTommy Li, Joseph P Balthasar
The AAPS Journal|July 29, 2009
Investigation of the influence of FcRn on the distribution of IgG to the brainAmit Garg, Joseph P Balthasar
Molecular Pharmaceutics|July 31, 2012
Investigation of the role of FcγR and FcRn in mAb distribution to the brainLubna Abuqayyas, Joseph P Balthasar
International Journal of Pharmaceutics|September 29, 2012
Application of knockout mouse models to investigate the influence of FcγR on the tissue distribution and elimination of 8C2, a murine IgG1 monoclonal antibodyLubna Abuqayyas, Joseph P Balthasar
Journal of Pharmacokinetics and Pharmacodynamics|July 20, 2007
Physiologically-based pharmacokinetic (PBPK) model to predict IgG tissue kinetics in wild-type and FcRn-knockout miceAmit Garg, Joseph P Balthasar
Blood|November 30, 2006
Comparison of the effects of antibody-coated liposomes, IVIG, and anti-RBC immunotherapy in a murine model of passive chronic immune thrombocytopeniaRong Deng, Joseph P Balthasar
The AAPS Journal|April 25, 2012
Pharmacokinetic mAb-mAb interaction: anti-VEGF mAb decreases the distribution of anti-CEA mAb into colorectal tumor xenograftsLubna Abuqayyas, Joseph P Balthasar
Journal of Pharmaceutical Sciences|November 14, 2018
Application of Physiologically Based Pharmacokinetic Modeling to Predict the Effects of FcRn Inhibitors in Mice, Rats, and MonkeysTommy Li, Joseph P Balthasar
Pageof 9